Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Otitis Externa

ClinicalTrials.gov lists 12 trials for Otitis Externa or a narrower condition beneath it. Otic Pharma has the most among industry and government lead sponsors, with 3.

MeSH D010032 Otorhinolaryngologic Diseases C09
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 4 Phase 3 Phase 3 4 Not applicable Not applicable 2 Observational Observational 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 4 Phase 3 Phase 3 4 Not applicable Not applicable 2 Observational Observational 1

Trials per phase

12 of the 12 trials are tagged with Otitis Externa itself; the rest are tagged with a narrower condition beneath it.

Get the Otitis Externa report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Otitis Externa trials start? (10)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1/2
  • Phase 2
  • Phase 3
  • Not applicable
  • Observational

Top of scale: 2

2008: 2 trials (Phase 3 1, Phase 2 1) 2009: 1 trials (Phase 1/2 1) 2010: 1 trials (Phase 2 1) 2011: 1 trials (Phase 2 1) 2012: 1 trials (Phase 3 1) 2013: 1 trials (Phase 3 1) 2015: 2 trials (Observational 1, Phase 2 1) 2016: 1 trials (Phase 3 1) 2022: 1 trials (Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2022 1
2016 1
2015 2
2013 1
2012 1
2011 1
2010 1
2009 1
2008 2

No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 12 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Otitis Externa trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1/2 1
Phase 2 4
Phase 3 4
Not applicable 2
Observational 1

How many Otitis Externa trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 1
Completed 8
Terminated 3

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Otitis Externa trials? (7)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Otic Pharma 3
Otonomy, Inc. 2
Alcon Research 1
Bitop AG 1
Circius Pharma AB 1

Interventions as named in the registry (15)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
0.3% Ciprofloxacin Ear Drops 2
Dexamethasone phosphate otic solution 1
Diclofenac 3% 1
dexotc 1
CIPRODEX® (ciprofloxacin 0.3%/dexamethasone 0.1%) 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Otitis Externa? (11)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Head-to-Head Comparison Between <sup>18</sup>F-FDG PET and Leukocyte Scintigraphy to Monitor Treatment Responses in Necrotizing Otitis Externa. Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 2024 Yes
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial. JAMA network open 2022 Yes
Oxythiamine improves antifungal activity of ketoconazole evaluated in canine Malassezia pachydermatis strains. Veterinary dermatology 2018 Yes
Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. The Pediatric infectious disease journal 2009 Yes
Otomycosis: clinical features and treatment implications. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2006 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages